The market's initial reaction to large percentage spikes is to flood the internet with short-centric fear and doubt. The market wants to short down the spike and shake out day traders who don't have a clue about why the price moved. They want to trigger stop losses..
The biggest volume action, besides the morning, was around 1:00-1:20 when The Street was putting together their little press release warning people about NLST's past track record without giving any analysis as to what these patent allowances and affirmations mean to the bottom line, in the long run. That is no coincidence.
After that little flurry around the Street's PR, the price held stable the rest of the day as someone is willing to absorb shares.
Agree with the long term outlook, near term dips and volatility will pass as time moves forward and these bullet points are realized. NLST must be aware that they needed the PPS to remain above 1.00$ for 10 days and I hope they scheduled the earnings call early in order to provide the clarity the market needs to keep it over $1.00.
If they have a good outlook for 2014, it would be better to announce early to give strength to the PPS as the delisting deadline comes in March. They couldn't know the PPS would stick as it did, avoiding delisting notice, but having it early would just be added insurance to keep PPS over $1.00 if news is good. If news is tepid, they would have run the risk of getting that delisting notice by announcing early.
It is unusual for The Street to keep putting out PRess releases, don't they think we all have seen the prior two.
Every single company who ever thinks about needing capital somewhere along the way needs to file an S-3 shelf filing. Many companies do it routinely as they have limited life-spans, they need to be renewed every few years. Often, the company filing will NEVER need to tap funds from a shelf filing, they go unused. Pretty much every development level biotech has a shelf filing to enable them the ability to raise when necessary.
Shelf filing with the SEC is not a notice of dilution, though they can lead to a dilution down the road when the share price is more optimal... If WYY does have another contract announcement coming soon, they might want to wait to think about raising capital in this shelf, announce good news and let the market realize the potential so you can raise at a higher price because the demand for shares will be greater.
SMOD's actions reveal what they're truly like, their patent was tossed in December because they withheld prior art. Their injuction against NLST was denied in June. SMOD/Diablo stole NLST IP design.
Their memory IP will be in the next generation DDR4. That has been the main issue, the industry had to catch up to their products. In the meantime, the big boys have tried to drive NLST into bankruptcy through patent re-exams and court filings. Delay delay delay. NVault has been catching on strongly now, surprisingly so.
I hope people realize you're here to just be devil's advocate. The USPTO tossed patent 295, they denied the injunction. Netlist has prior art that SMOD did not provide the patent office.
Correct me if I'm wrong, but Vault still gathers revenue in dollars and not pieces of candy? If Vault carries the load now, nothing wrong with that...
New PR after hours, "The two newly added patents (U.S. Patent Nos. 7,881,150 and 8,081,536) are generally related to load reduction, a critical feature in low latency memory modules. These patents are part of the same family as U.S. Patent No. 7,532,537, which has been upheld by the Patent Trial and Appeal Board ("PTAB") following a three-year reexamination. The '150 and '536 patents were examined and issued in view of prior art cited in the reexamination. Netlist has now asserted a total of seven patents against the ULLtraDIMM, in addition to trade secret theft, trademark infringement and other claims. "
They're banking on the fact that the majority of the market place has no clue about NLST, which is probably a fair assessment.
Interesting. This has all the hallmarks of becoming a great expose on 60 minutes, imagine a "Mike Wallace-like" grilling some Diablo executive, certainly worthy of the spotlight.
Intel must see the value in this, otherwise they wouldn't bother working with NLST for 3 years. People that are buying/accumulating today are not worried about Monday, they're looking ahead a year.
The same question can be asked, why didn't it go over $2.00 on earnings surprise beat. Finances. They raised cash to ramp inventory, to raise stockholder's equity. They now can remain on Nasdaq, no worries about delisting. They just announced a supply deal with Avere, who supplies Amazon with servers. They have a whistle-blower providing them with information in their case against Diablo/SmartMod = SanDisk. They had their integral patent upheld after 3+ years in USPTO re-exams, vs. IPHI...
Just browse this message board a little and you can catch up, Mo.
Forget about things we don't know. Focus on what we do know. Listen to the Needham Presentation again, read the whistle blower docs again, read the USPTO decisions again, read the supplier deal with Avere who has an agreement with Amazon again, read the DDR4 IP adoption again... The 1 year outlook is the reason we are seeing this Float churn and churn while entities are accumulating.